Yu K C, Jiang Y, Chen W, Cooper A D
Research Institute, Palo Alto Medical Foundation, Palo Alto, CA 94301, USA.
J Lipid Res. 2000 Nov;41(11):1715-27.
Apolipoprotein E (apoE) is a ligand for the low density lipoprotein receptor (LDLR) and the low density lipoprotein receptor-related protein (LRP). The aim of the present study was to clarify the role of hepatically localized apoE in the rapid initial removal of chylomicron remnants by using the isolated perfused liver. Radiolabeled chylomicron remnants were perfused in a single nonrecirculating pass into the livers of C57BL/6J (wild-type) mice, apoE-knockout mice, and apoE/LDLR-knockout mice for a period of 20 min. Aliquots of the perfusate leaving the liver were collected at regular intervals and the rate of removal of radioactivity was determined. At a trace concentration of chylomicron remnants (0.05 microgram of protein per ml), wild-type mouse livers removed at a steady state of 50-55% of total chylomicron remnants perfused per pass; livers from apoE-knockout mice had the same capacity as wild-type mouse livers. When the concentration of remnants was increased to 12 microgram of protein per ml, a level at which it has been shown that LDL receptor and LRP are near saturation, the capacity of the wild-type mouse livers to remove chylomicron remnants was decreased to 10-25% per pass, confirming that the removal mechanisms were nearing saturation. However, instead of finding a greater reduction in the removal rates or impairment in chylomicron remnant removal, livers from apoE-knockout mice were just as efficient as those from wild-type mice in removing remnants. Livers of mice that lacked both apoE and the LDLR also had a similar rate of removal at relatively low remnant concentrations (0.05-0.5 microgram/ml), but had reduced capacity in removing remnants at a relatively high concentration (4-12 microgram/ml) of chylomicron remnants ( approximately 20% per pass). The rate of removal at these concentrations, however, was similar to that attributed to the LRP in previous studies. Chylomicron remnants, whose apolipoproteins were disrupted by trypsinization, were removed at a normal rate by wild-type mouse livers but there was almost no removal by apoE-knockout mouse livers. At higher concentrations, however, the removal of apolipoprotein-disrupted chylomicron remnants was decreased. Our present findings do not support the hypothesis that hepatically localized apoE is a critical factor in the rapid initial removal of chylomicron remnants by either of the major pathways but do suggest that hepatically localized apoE can be added to lipoproteins to accelerate their uptake, although this process may have a limited capacity to compensate for apoE deficiency on lipoproteins.
载脂蛋白E(apoE)是低密度脂蛋白受体(LDLR)和低密度脂蛋白受体相关蛋白(LRP)的配体。本研究的目的是通过使用离体灌注肝脏来阐明肝脏局部apoE在乳糜微粒残粒快速初始清除中的作用。将放射性标记的乳糜微粒残粒以单次非循环灌注的方式注入C57BL/6J(野生型)小鼠、apoE基因敲除小鼠和apoE/LDLR基因敲除小鼠的肝脏中,持续20分钟。定期收集离开肝脏的灌注液等分试样,并测定放射性的清除率。在乳糜微粒残粒的微量浓度(每毫升0.05微克蛋白质)下,野生型小鼠肝脏在每次灌注中以稳定状态清除灌注的总乳糜微粒残粒的50 - 55%;apoE基因敲除小鼠的肝脏与野生型小鼠的肝脏具有相同的清除能力。当残粒浓度增加到每毫升12微克蛋白质时,已表明此时LDL受体和LRP接近饱和,野生型小鼠肝脏清除乳糜微粒残粒的能力降至每次灌注10 - 25%,这证实清除机制已接近饱和。然而,apoE基因敲除小鼠的肝脏在清除残粒方面并没有出现清除率进一步大幅降低或乳糜微粒残粒清除受损的情况,其清除效率与野生型小鼠的肝脏相同。同时缺乏apoE和LDLR的小鼠肝脏在相对低的残粒浓度(0.05 - 0.5微克/毫升)下也有类似的清除率,但在相对高浓度(4 - 12微克/毫升)的乳糜微粒残粒下清除能力降低(每次灌注约20%)。然而,这些浓度下的清除率与先前研究中归因于LRP的清除率相似。经胰蛋白酶处理使载脂蛋白被破坏的乳糜微粒残粒,野生型小鼠肝脏能以正常速率清除,但apoE基因敲除小鼠的肝脏几乎没有清除。然而,在较高浓度下,载脂蛋白被破坏的乳糜微粒残粒的清除率降低。我们目前的研究结果不支持肝脏局部apoE是通过任何一种主要途径快速初始清除乳糜微粒残粒的关键因素这一假说,但确实表明肝脏局部apoE可以添加到脂蛋白中以加速其摄取,尽管这一过程补偿脂蛋白上apoE缺乏的能力可能有限。